Ablation of Src Family Kinases FGR in hosts reduces confers response of high-grade ovarian cancer to immune checkpoint blockade treatment

被引：0
|
作者：
Ernst, M. [1 ]
Poh, A. [2 ]
Christie, E. [3 ]
机构：
[1] Olivia Newton John Canc Res Inst, Canc & Inflammat, Heidelberg, Vic, Australia
[2] Olivia Newton John Canc Res Inst, Canc Inflammat Lab, Heidelberg, Vic, Australia
[3] Peter MacCallum Canc Ctr, Canc Evolut & Metastasis Program, Melbourne, Vic, Australia
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 211卷
关键词：
D O I：
10.1016/j.ejca.2024.114984
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PB-506
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 43 条
  • [1] STING agonist treatment increases response to chemotherapy and immune checkpoint blockade therapy in a syngeneic murine model of high-grade serous ovarian cancer
    Ghaffari, Abdi
    Peterson, Nichole
    Khalaj, Kasra
    Robinson, Andrew
    Francis, Julie-Ann
    Koti, Madhuri
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [2] The immune landscape of high-grade brain tumor after treatment with immune checkpoint blockade
    Park, Jang Hyun
    Kang, In
    Lee, Heung Kyu
    FRONTIERS IN IMMUNOLOGY, 2022, 13 : 1044544
  • [3] Identification of a novel biomarker response in a prospective clinical trial of immune checkpoint blockade in high-grade serous ovarian carcinoma
    Cun, H.
    Hinchcliff, E. M.
    Zhu, Y.
    Ferri-Borgogno, S.
    Cheng, R.
    Burks, J. K.
    Wong, S. T. C.
    Jazaeri, A. A.
    Mok, S. C.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 143 - 143
  • [4] Spontaneous Regression and Complete Response to Immune Checkpoint Blockade in a Case of High-Grade Neuroendocrine Carcinoma
    Raufi, Alexander G.
    May, Michael
    Greendyk, Richard A.
    Iuga, Alina
    Ahmed, Firas
    Mansukhani, Mahesh
    Manji, Gulam A.
    JCO PRECISION ONCOLOGY, 2020, 4 : 1006 - 1011
  • [5] STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer
    Abdi Ghaffari
    Nichole Peterson
    Kasra Khalaj
    Natasha Vitkin
    Andrew Robinson
    Julie-Ann Francis
    Madhuri Koti
    British Journal of Cancer, 2018, 119 : 440 - 449
  • [6] STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer
    Ghaffari, Abdi
    Peterson, Nichole
    Khalaj, Kasra
    Vitkin, Natasha
    Robinson, Andrew
    Francis, Julie-Ann
    Koti, Madhuri
    BRITISH JOURNAL OF CANCER, 2018, 119 (04) : 440 - 449
  • [7] Prexasertib: an investigational checkpoint kinase inhibitor for the treatment of high-grade serous ovarian cancer
    Evangelisti, Giulio
    Barra, Fabio
    Moioli, Melita
    Sala, Paolo
    Stigliani, Sara
    Gustavino, Claudio
    Costantini, Sergio
    Ferrero, Simone
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (08) : 779 - 792
  • [8] High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience
    Nasr, Lewis F.
    Zoghbi, Marianne
    Lazcano, Rossana
    Nakazawa, Michael
    Bishop, Andrew J.
    Farooqi, Ahsan
    Mitra, Devarati
    Guadagnolo, Beverly Ashleigh
    Benjamin, Robert
    Patel, Shreyaskumar
    Ravi, Vinod
    Araujo, Dejka M.
    Livingston, Andrew
    Zarzour, Maria A.
    Conley, Anthony P.
    Ratan, Ravin
    Somaiah, Neeta
    Lazar, Alexander J.
    Roland, Christina
    Keung, Emily Z.
    Haddad, Elise F. Nassif
    CANCERS, 2024, 16 (09)
  • [9] C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer
    Zhang, Chen
    Cao, Kankan
    Yang, Moran
    Wang, Yiying
    He, Mengdi
    Lu, Jiaqi
    Huang, Yan
    Zhang, Guodong
    Liu, Haiou
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [10] Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer
    Wan, Changxin
    Keany, Matthew P.
    Dong, Han
    Al-Alem, Linah F.
    Pandya, Unnati M.
    Lazo, Suzan
    Boehnke, Karsten
    Lynch, Katherine N.
    Xu, Rui
    Zarrella, Dominique T.
    Gu, Shengqing
    Cejas, Paloma
    Lim, Klothilda
    Long, Henry W.
    Elias, Kevin M.
    Horowitz, Neil S.
    Feltmate, Colleen M.
    Muto, Michael G.
    Worley, Michael J.
    Berkowitz, Ross S.
    Matulonis, Ursula A.
    Nucci, Marisa R.
    Crum, Christopher P.
    Rueda, Bo R.
    Brown, Myles
    Liu, Xiaole Shirley
    Hill, Sarah J.
    CANCER RESEARCH, 2021, 81 (01) : 158 - 173
12345